All News

Understanding the peer review process can increase your appreciation for the medical literature and help you publish your manuscript.

Learn about the new drugs and expanded indications approved by the FDA in November 2015.

A pharmacist stood her ground while a man verbally attacked her for wearing a hijab at her store.

Treatment with bevacizumab and lomustine not found to offer a survival advantage.

Top recent news in cancer drug development.

NS3 enzyme interacts with RNA and helps the pathogen replication process.

Chemosensitivity, treatment variations, and socioeconomic factors may be a significant factor.

Excess production of tumor necrosis factor causes both RA and the onset of heart valve disease.

Depression and smoking status may be valuable targets for interventions from care providers.

Engineered antibody treatment imitates functioning factor VIII to make blood clot properly.

Catch up with any news you missed this week on Specialty Pharmacy Times.

Psychosis and hepatic fibrosis associated with earlier mortality.

Processed and red meat products like bacon and salami previously deemed carcinogenic to humans.

Legislators focus on the pricing of sofosbuvir and Harvoni.

Stelara has already been approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in several countries.

Janssen is seeking FDA approval for ustekinumab as a Crohn's disease treatment.

A measure to delay the unpopular "Cadillac tax," part of President Obama's health reform law, overwhelmingly passed the Senate by a 90-10 vote on Thursday.

Warnings about the risk of ketoacidosis and serious urinary tract infections have been added to the labels of SGLT2 inhibitors.

An amendment calling for personal importation of prescription drugs from Canada was withdrawn amidst debate in the U.S. Senate on budget reconciliation legislation yesterday.

AbbVie has announced the launch of the AbbVie Crohn's & Colitis Scholarship, designed to provide financial support for exceptional students living with inflammatory bowel disease (IBD) as they pursue higher education goals.

Johnson & Johnson has announced the completion of the acquisition of Novira Therapeutics, a privately held, clinical-stage biopharmaceutical company developing innovative therapies for curative treatment of chronic hepatitis B virus infection.

The World Health Organization indicates that 35 million individuals have HIV worldwide, and 4 to 5 million HIV-infected patients are co-infected with hepatitis C virus.

The National Association of Chain Drug Stores (NACDS) Foundation celebrated its 17th Annual Foundation Dinner last evening in New York City, New York.

We're heading towards a major disruption in health care technology.

Nonsteroidal anti-inflammatory drugs, acetaminophen, and other non-opioid OTC analgesics used to treat pain are particularly difficult for patients to self-manage.